Authors



Nano PharmaSolutions, Inc.

Latest:

Physical Nanoformulation for Solubility Enhancement of Poorly Soluble Drugs

Nano PharmaSolutions developed a new nanoformulation for improving solubility of drug molecules, which can save several months of preclinical stage of drug development.


William Bakewell

Latest:

Selecting and Optimizing the Right Manufacturing Partner

Optimizing the use of partners for clinical trials depends on selecting the right contractor.


Nicholas Saraceno

Latest:

FDA Grants Approval to Kedrion to Produce PLGD-1 Therapeutic at Bolognana Plant

FDA's approval will allow Kedrion to manufacture Ryplazim (plasminogen, human-tvmh), the only FDA-approved therapy for treating PLGD-1, at facility in Bolognana, Italy.


Michael Hill

Latest:

A Novel Cell Lysis Method to Improve the Viral Vector Manufacturing Process

Researchers demonstrated a new cell lysis method using a novel solution to improve viral vector production.


Aeshna Amin

Latest:

Variables Affecting Reconstitution Time of Dry Powder for Injection

The authors describe the factors affecting reconstitution time of dry powder for injection and classifies them as intrinsic and extrinsic parameters.


Don Henry

Latest:

High-Quality Communication Enables High-Quality Drug Products

User fee programs have improved FDA’s approval timeline for important therapies.


Toby Blackburn

Latest:

Accelerating Scientific Research Using the Cloud

The “cloud lab” is a virtual laboratory setting that can enable scientists to more quickly advance research.


Stephanie Snow

Latest:

Nitrosamine Impurities in Medicinal Products

Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.


Varanya Chaiyaperm

Latest:

Pharmaceutical Compounding Calculations in a Workplace Environment

An ordered process describing calculations activities for compounded dosage forms is described.


Bora Pharmaceuticals

Latest:

Addressing the complex demands of cell line development

Having a robust Cell Line Development (CLD) strategy is the foundation of biologic production that can propel a project, helping to streamline production while mitigating risk. A tailored and optimized cell line can be instrumental in overcoming development and manufacturing challenges and achieving a competitive advantage in the market with streamlined manufacturing processes. In this eBook, Bora Biologics describes how a robust CLD strategy can help biologics developers anticipate and overcome challenges and streamline production.


Mark D. Argentine

Latest:

Restructuring Method Transfer Through Global Sites

Method-transfer kits help simplify analytical method transfer for global site certifications.


Mikart

Latest:

Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia

Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia


Theresa Mullin

Latest:

The Global Regulatory Village

Harmonization of global regulations fosters innovation and ensures quality medicines.


Francis Roganti

Latest:

Design of an Aseptic Process Simulation

The authors suggest a design strategy for an aseptic process simulation that focuses on the basic repeating unit of the process, establishing alert and action criteria for the unit itself, and using worst-case simulations to establish routine operational parameters for the manufacturing process.


Emma Ramnarine

Latest:

Control Strategy: A Feedback-Feedforward ‘Controls Hub’ for Risk, Knowledge, and Product Lifecycle Management

A control strategy can function as a powerful “hub” to gain a comprehensive understanding of the consolidated set of controls that are necessary to ensure consistent delivery of quality product.


Ryanka Chauhan

Latest:

Overcoming Data Gaps in Pharmacovigilance

By leveraging certain strategies, organizations can effectively close data gaps and achieve more accurate and effective machine learning models in pharmacovigilance.


Nanoform

Latest:

STARMAP® Online: Empowering Therapeutic Development with Sparse-Data AI

Learn how STARMAP® Online cultivates an advantageous outlook for customers through accessible CESS®-powered nanoparticle technology. This platform can reduce the time, cost, and risk of drug development, as well as use AI to assure data privacy and streamline decision-making for patients.


MJH Life Sciences

Latest:

Michael J. Hennessy: MM&M 40 Under 40 Award

Michael J. Hennessy Jr., president and CEO of MJH Life Sciences™, parent company to Pharmaceutical Technology, named to MM&M’s second annual 40 Under 40 list.


Zillery A. Fortner

Latest:

Mitigating Third-Party Risks: The Benefits of Extending Quality to the Supply Chain

The functionality of a digital quality management system (QMS) provides visibility into critical supplier activity and helps ensure a high-quality product.


Rajasekhar Jaladi, PhD

Latest:

Assessment of Nanosuspension Formulation for Intranasal Administration

Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.


Jennifer Putnam

Latest:

Mitigating the Risk from Excipient Variability

This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.


Klaus Lindpaintner

Latest:

Using Novel Biomarkers to Facilitate AI-Driven Glycoproteomics

With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.



John Lewis

Latest:

Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

Collaboration is a key component to achieving long-term success with genetic medicines.


CPHI Content Team

Latest:

Innovative Start-Ups at CPHI Barcelona

The Start-Up Market at CPHI Barcelona will bring together 27 start-ups, innovators, and small enterprises from across the pharma landscape.


Veolia

Latest:

Mitigating Pharmaceutical Production Risks Using Hot Water for Injection and Pure Steam

Webinar Date/Time: Wed, Feb 7, 2024 10:30 AM CET (4:30 AM EST)



Luke Hamm

Latest:

Continued Innovation is Key for COVID-19 Recovery

More work is needed to educate businesses on the value of innovation and the availability of funding.